Asian shares try to stabilise, China growth a worry



* Asian stock markets : Link

* Nikkei edges off 7-mth lows, China shares steady for now

* U.S. stock futures firm as earnings beat expectations

* Senate looks to pass infrastructure deal; payrolls ahead

By Wayne Cole

SYDNEY, Aug 2 (Reuters) - Asian shares were seeking a modicum of stability on Monday as a run of stellar U.S. corporate earnings put a floor under markets, though Beijing's regulatory crackdown continued to reverberate amid disappointing economic news.

China's woes were underlined by surveys showing factory activity slowing sharply in July amid rising costs and extreme weather.

In contrast, Europe's economic recovery outpaced all expectations last quarter, while U.S consumers spent with abandon in June as coronavirus restrictions eased, a trend likely to ensure a strong payrolls report at the end of this week.

"Surging company profits in the U.S. and lower bond yields are providing support, and in any case the rising trend in shares is likely to remain in place into next year as rising vaccination rates allow economic recovery to continue," said Shane Oliver, chief investment strategist at AMP Capital.

About 89% of the nearly 300 recent U.S. earnings reports have beaten analysts' profit estimates. Earnings are now expected to have climbed 89.8% in the second quarter, versus forecasts of 65.4% at the start of July.

There was also the prospect of more fiscal stimulus ahead as U.S. senators worked to finalise a sweeping $1 trillion infrastructure plan that could pass this week.

The optimism was apparent on Wall Street with S&P 500 futures ESc1 rising 0.5% and Nasdaq futures NQc1 0.4%. EUROSTOXX 50 futures STXEc1 added 0.3%, while FTSE futures FFIc1 gained 0.2%/

Asia has not fared so well, with China's crackdown on the tech and education sectors hammering stocks, while the spread of the Delta variant of the coronavirus in the region hit growth.

MSCI's broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS was last up 0.2%, having hit its low for the year so far last week.

Japan's Nikkei .N225 bounced back 1.6%, but that was from its lowest since January. Investors were anxiously watching Chinese blue chips .CSI300 which gained 0.9%, after shedding 5.5% last week.

"The 10-15 year period where foreign investors were allowed to participate in the walled garden of Chinese high growth stocks was an aberration," said BofA economist Ajay Kapur.

A shift in China's regulatory regime was underway that held implication well beyong the tech sector, he said.

"Regulatory tightening in the world's second largest economy intended to reduce inequality and make housing and goods more affordable is deflationary, something that the many bond bears need to consider."

Equity valuations elsewhere have already been supported by a steady decline in bond yields, with yields on U.S. 10-year notes US10YT=TWEB falling for five weeks in a row to reach 1.23%.

That drop combined with surprisingly strong EU economic data out on Friday to lift the euro to $1.1866 EUR= , away from its July low of $1.1750.

The dollar has also drifted off to 109.67 yen JPY= , from its recent top of 110.58, but has support around 109.35. As a result, the dollar index has eased to 92.110 =USD , from a July peak of 93.194.

The drop in bond yields and the dollar gave gold a fillip last week but it again faltered at resistance around $1,832 and was last trading flat at $1,811 an ounce XAU= .

Oil prices eased on Monday as soft Chinese data undermined the outlook for demand, though that follows four straight months of price gains.

Brent LCOc1 was last down $1.02 at $74.39 a barrel, while U.S. crude CLc1 lost 91 cents to $73.04.



Asia stock markets Link
Asia-Pacific valuations Link



Editing by Kenneth Maxwell; Editing by Simon Cameron-Moore


Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Usamos cookies para lhe dar a melhor experiência no nosso website. Ler mais ou alterar as configurações de cookies.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.